Atonomics, Beckman Coulter deal

Beckman Coulter partnered with Atonomics to develop diagnostics for Atonomics' Atolyzer immuno-diagnostic system. Atolyzer is in early development for use in a near-patient setting for indications including cardiovascular diseases, prostate cancer and maternal health. Atonomics received an undisclosed equity investment from Beckman, which now holds an undisclosed minority stake in the company. Further terms were not disclosed. ...